In September, the Launchbay25 Index rose by 9 points (5.3%), driven by strong performance from OpenAI, Neuralink, and Cerebras. OpenAI is nearing the close of a new primary round at a $150B valuation, Neuralink gained FDA approval for its new "blindsight" implant, and Cerebras is preparing for its IPO with solid fundamentals.